Lenacapavir, trialed in Uganda, offers 100% protection but will it reach those who need it most? Kampala, Uganda | RONALD ...

Over 7 000 have undergone safe medical circumcision since June, boosting HIV prevention efforts across the Limpopo province.

Kenya has been selected as one of the 9 early adopter countries for the rollout of Lenacapavir (LEN), a long-acting ...

A pivotal moment in the fight to end AIDS -- ensuring lifesaving innovation reaches those who need it most, wherever they live ...

Kenya is among nine African countries, under the low- and middle-income category, that are set to be among the early beneficiaries of lenacapavir, a long-acting HIV prevention drug, following a recent ...

Unfortunately, the Trump administration and the Republican majorities in Congress are putting access to lifesaving ...

The World Health Organization is now recommending that countries include an HIV drug newly approved for prevention as a tool ...

The Trump administration has lifted a freeze on federal funds for HIV prevention and surveillance programs, officials said, following an outcry from HIV prevention organizations, health experts ...

The Trump administration has lifted a freeze on federal funds for HIV prevention and surveillance programs, officials said, following an outcry from HIV prevention organizations, health experts ...

In a sweeping national overhaul of HIV prevention funding, the CDC chose to bypass local and statewide community organizations like AVOL Kentucky.

Colorado health providers cheer the approval but say the drug costs $14,000 per shot. Yeztugo is the first and only injectable HIV prevention medication.

Gilead’s twice-a-year HIV prevention drug lenacapavir is 30 years in the making. Here’s the story behind it.